Literature DB >> 19809486

Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level.

Rinse Klooster1, Kirsten Straasheijm, Bharati Shah, Janet Sowden, Rune Frants, Charles Thornton, Rabi Tawil, Silvère van der Maarel.   

Abstract

In facioscapulohumeral muscular dystrophy (FSHD) the majority of patients carry a D4Z4 macrosatellite repeat contraction in the subtelomere of chromosome 4q. Several disease mechanisms have been proposed to explain how repeat contraction causes muscular dystrophy. All proposed mechanisms foresee a change from a closed to a more open chromatin structure followed by loss of control over expression of genes in or proximal to D4Z4. Initially, a distance and residual repeat size-dependent upregulation of the candidate genes FRG2, FRG1 and ANT1 was observed, but most successive expression studies failed to support transcriptional upregulation of 4qter genes. Moreover, chromatin studies do not provide evidence for a cis-spreading mechanism operating at 4qter in FSHD. In part, this inconsistency may be explained by differences in the techniques used, and the use of RNA samples obtained from different muscle groups. The aim of this study is to comprehensively and uniformly study the expression of the FSHD candidate genes FRG1, FRG2, CRYM, ANT1, ALP, PITX1 and LRP2BP at the RNA and protein level in identically processed primary myoblasts, myotubes and quadriceps muscle. Expression was compared between samples obtained from FSHD patients and normal controls with samples from myotonic dystrophy type 1 patients as disease controls. No consistent changes in RNA or protein expression levels were observed between the samples. The one exception was a selective increase in FRG2 mRNA expression in FSHD myotubes. This study provides further evidence that there is no demonstrable consistent, large magnitude, overexpression of any of the FSHD candidate genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809486      PMCID: PMC2987013          DOI: 10.1038/ejhg.2009.62

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  38 in total

1.  Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.

Authors:  J-T Vilquin; J-P Marolleau; S Sacconi; I Garcin; M-N Lacassagne; I Robert; B Ternaux; B Bouazza; J Larghero; C Desnuelle
Journal:  Gene Ther       Date:  2005-11       Impact factor: 5.250

2.  Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.

Authors:  K L Deak; R J L F Lemmers; J M Stajich; R Klooster; R Tawil; R R Frants; M C Speer; S M van der Maarel; J R Gilbert
Journal:  Neurology       Date:  2007-01-17       Impact factor: 9.910

Review 3.  Facioscapulohumeral muscular dystrophy.

Authors:  Silvère M van der Maarel; Rune R Frants; George W Padberg
Journal:  Biochim Biophys Acta       Date:  2006-06-06

4.  FRG1P-mediated aggregation of proteins involved in pre-mRNA processing.

Authors:  Silvana van Koningsbruggen; Kirsten R Straasheijm; Ellen Sterrenburg; Natascha de Graaf; Hans G Dauwerse; Rune R Frants; Silvère M van der Maarel
Journal:  Chromosoma       Date:  2006-11-14       Impact factor: 4.316

5.  A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.

Authors: 
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

6.  Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy.

Authors:  Patrick W Reed; Andrea M Corse; Neil C Porter; Kevin M Flanigan; Robert J Bloch
Journal:  Exp Neurol       Date:  2007-03-21       Impact factor: 5.330

7.  Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Marielle Wohlgemuth; Kristiaan J van der Gaag; Patrick J van der Vliet; Corrie M M van Teijlingen; Peter de Knijff; George W Padberg; Rune R Frants; Silvere M van der Maarel
Journal:  Am J Hum Genet       Date:  2007-09-07       Impact factor: 11.025

8.  Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD.

Authors:  J C de Greef; M Wohlgemuth; O A Chan; K B Hansson; D Smeets; R R Frants; C M Weemaes; G W Padberg; S M van der Maarel
Journal:  Neurology       Date:  2007-09-04       Impact factor: 9.910

9.  Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype.

Authors:  E Ricci; G Galluzzi; G Deidda; S Cacurri; L Colantoni; B Merico; N Piazzo; S Servidei; E Vigneti; V Pasceri; G Silvestri; M Mirabella; F Mangiola; P Tonali; L Felicetti
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

10.  Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1.

Authors:  Davide Gabellini; Giuseppe D'Antona; Maurizio Moggio; Alessandro Prelle; Chiara Zecca; Raffaella Adami; Barbara Angeletti; Patrizia Ciscato; Maria Antonietta Pellegrino; Roberto Bottinelli; Michael R Green; Rossella Tupler
Journal:  Nature       Date:  2005-12-11       Impact factor: 49.962

View more
  36 in total

1.  The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.

Authors:  Petr Dmitriev; Andrei Petrov; Eugenie Ansseau; Luiza Stankevicins; Sébastien Charron; Elena Kim; Tomas Jan Bos; Thomas Robert; Ahmed Turki; Frédérique Coppée; Alexandra Belayew; Vladimir Lazar; Gilles Carnac; Dalila Laoudj; Marc Lipinski; Yegor S Vassetzky
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function.

Authors:  Sachiko Homma; Jennifer C J Chen; Fedik Rahimov; Mary Lou Beermann; Kendal Hanger; Genila M Bibat; Kathryn R Wagner; Louis M Kunkel; Charles P Emerson; Jeffrey Boone Miller
Journal:  Eur J Hum Genet       Date:  2011-11-23       Impact factor: 4.246

Review 3.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  A unifying genetic model for facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Rinse Klooster; Sabrina Sacconi; Pilar Camaño; Johannes G Dauwerse; Lauren Snider; Kirsten R Straasheijm; Gert Jan van Ommen; George W Padberg; Daniel G Miller; Stephen J Tapscott; Rabi Tawil; Rune R Frants; Silvère M van der Maarel
Journal:  Science       Date:  2010-08-19       Impact factor: 47.728

5.  Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression.

Authors:  Beverly A Teicher; Eric Polley; Mark Kunkel; David Evans; Thomas Silvers; Rene Delosh; Julie Laudeman; Chad Ogle; Russell Reinhart; Michael Selby; John Connelly; Erik Harris; Anne Monks; Joel Morris
Journal:  Mol Cancer Ther       Date:  2015-09-08       Impact factor: 6.261

6.  Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity.

Authors:  Emanuela Teveroni; Marsha Pellegrino; Sabrina Sacconi; Patrizia Calandra; Isabella Cascino; Stefano Farioli-Vecchioli; Angela Puma; Matteo Garibaldi; Roberta Morosetti; Giorgio Tasca; Enzo Ricci; Carlo Pietro Trevisan; Giuliana Galluzzi; Alfredo Pontecorvi; Marco Crescenzi; Giancarlo Deidda; Fabiola Moretti
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

Review 7.  Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Antioxid Redox Signal       Date:  2014-12-04       Impact factor: 8.401

8.  Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD.

Authors:  Yvonne D Krom; Julie Dumonceaux; Kamel Mamchaoui; Bianca den Hamer; Virginie Mariot; Elisa Negroni; Linda N Geng; Nicolas Martin; Rabi Tawil; Stephen J Tapscott; Baziel G M van Engelen; Vincent Mouly; Gillian S Butler-Browne; Silvère M van der Maarel
Journal:  Am J Pathol       Date:  2012-08-04       Impact factor: 4.307

Review 9.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

10.  Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei.

Authors:  Peter S Masny; On Ying A Chan; Jessica C de Greef; Ulla Bengtsson; Melanie Ehrlich; Rabi Tawil; Leslie F Lock; Jane E Hewitt; Jennifer Stocksdale; Jorge H Martin; Silvere M van der Maarel; Sara T Winokur
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.